F Xue, J Cheng, Y Liu, C Cheng,
M Zhang… - … and Targeted Therapy, 2022 - nature.com
Abstract Angiotensin-converting enzyme 2 (ACE2) has proven beneficial in attenuating
diabetic cardiomyopathy (DCM) but has been found to be a substrate of a disintegrin and …